Literature DB >> 31078214

The Pathophysiology of Dyspnea and Exercise Intolerance in Chronic Obstructive Pulmonary Disease.

Denis E O'Donnell1, Matthew D James2, Kathryn M Milne3, J Alberto Neder2.   

Abstract

Dyspnea, the most common symptom in chronic obstructive pulmonary disease (COPD), often becomes disabling in advanced stages of the disease. Chronic dyspnea erodes perceived health status and diminishes engagement in physical activity, often leading to skeletal muscle deconditioning, anxiety, depression, and social isolation. Broader understanding of the pathophysiologic underpinnings of dyspnea has allowed us to formulate a sound rationale for individualized management. This review examines recent research and provides historical context. The overarching objectives are to consider current constructs of the physiologic mechanisms of activity-related dyspnea and identify specific targets amenable to therapeutic manipulation in patients with COPD.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; Dyspnea; Exercise physiology; Inspiratory neural drive; Respiratory mechanics

Mesh:

Year:  2019        PMID: 31078214     DOI: 10.1016/j.ccm.2019.02.007

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  11 in total

Review 1.  Pathophysiology and clinical evaluation of the patient with unexplained persistent dyspnea.

Authors:  Andi Hudler; Fernando Holguin; Meghan Althoff; Anne Fuhlbrigge; Sunita Sharma
Journal:  Expert Rev Respir Med       Date:  2022-01-20       Impact factor: 4.300

Review 2.  Management of Refractory Breathlessness: a Review for General Internists.

Authors:  Annie Massart; Daniel P Hunt
Journal:  J Gen Intern Med       Date:  2021-01-19       Impact factor: 5.128

Review 3.  Breathlessness and the brain: the role of expectation.

Authors:  Lucy L Marlow; Olivia K Faull; Sarah L Finnegan; Kyle T S Pattinson
Journal:  Curr Opin Support Palliat Care       Date:  2019-09       Impact factor: 2.302

4.  Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.

Authors:  Atsushi Miyamoto; Kazuhisa Asai; Hideaki Kadotani; Naomi Maruyama; Hiroaki Kubo; Atsuko Okamoto; Kanako Sato; Kazuhiro Yamada; Naoki Ijiri; Tetsuya Watanabe; Tomoya Kawaguchi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-27

5.  Quadriceps physiological response during the 1-min sit-to-stand test in people with severe COPD and healthy controls.

Authors:  Sarah Gephine; Patrick Mucci; Mathieu Bielmann; Mickael Martin; Laurent Bouyer; Didier Saey; François Maltais
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.996

6.  Acceptability of capnography-assisted respiratory therapy: a new mind-body intervention for COPD.

Authors:  Anna Migliore Norweg; Anne Skamai; Simona C Kwon; Jonathan Whiteson; Kyle MacDonald; Francois Haas; Eileen G Collins; Roberta M Goldring; Joan Reibman; Yinxiang Wu; Greg Sweeney; Alicia Pierre; Andrea B Troxel; Linda Ehrlich-Jones; Naomi M Simon
Journal:  ERJ Open Res       Date:  2021-12-20

7.  Impact of fan therapy during exercise on breathlessness and recovery time in patients with COPD: a pilot randomised controlled crossover trial.

Authors:  Alex Long; Martin Cartwright; Charles C Reilly
Journal:  ERJ Open Res       Date:  2021-11-08

8.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

9.  Association between obesity-related dyspnea in daily living, lung function and body composition analyzed by DXA: a prospective study of 130 patients.

Authors:  Jean Hagenburg; Eric Bertin; Jean-Hugues Salmon; Aurore Thierry; Jeanne-Marie Perotin; Valérian Dormoy; Sandra Dury; Isabelle Gaubil; Lois Bolko; François Lebargy; Gaëtan Deslee; Claire Launois
Journal:  BMC Pulm Med       Date:  2022-03-25       Impact factor: 3.317

10.  A randomized, crossover, placebo controlled, double-blind trial of the effects of tiotropium-olodaterol on neuromuscular performance during exercise in COPD.

Authors:  Min Cao; Robert A Calmelat; Peter Kierstead; Nicolo Carraro; William W Stringer; Janos Porszasz; Richard Casaburi; Harry B Rossiter
Journal:  J Appl Physiol (1985)       Date:  2022-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.